General Information of the Compound
Compound ID
CP0453721
Compound Name
5-Methyl-4-oxy-pyrazine-2-carboxylic acid
    Show/Hide
Synonyms
Acipimox
K 9321
Monted
Nedios
Olbemox
Olbetam
    Show/Hide
Structure
Formula
C6H6N2O3
Molecular Weight
154.125
Canonical SMILES
Cc1cnc(c[n+]1[O-])C(O)=O
    Show/Hide
InChI
InChI=1S/C6H6N2O3/c1-4-2-7-5(6(9)10)3-8(4)11/h2-3H,1H3,(H,9,10)
    Show/Hide
InChIKey
DJQOOSBJCLSSEY-UHFFFAOYSA-N
CAS
51037-30-0
Physicochemical Property
logP
-0.27838
Rotatable Bonds
1
Heavy Atom Count
11
Polar Areas
77.13
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Complexity
11

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 5310993
SID: 15219287
ChEMBL ID
CHEMBL345714
DrugBank ID
DB09055
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01282, Hydroxycarboxylic acid receptor 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
EC50 = 5300 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Acipimox )
Drug Name Acipimox
Company Pharmacia & Upjohn AB
Indication
Arteriosclerosis
Approved